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Diabetes mellitus ialah penyakit rnetabolik yang bercirikan hiperglisemia dan d islipidemia, yang memberi 
pesakit diabetes risiko tinggi untuk mendapat penyakit jantung. Adalah dipercayai bahawa LDL kolesterol 
(LDLC), trigliserida (TG) dan genotip apolipoprotein E (apo E) berkait rapat dalam menentukan risiko tinggi 
ini. Kajian ini bertujuan untuk mencirikan dislipidemia diabetes dengan penentuan saiz LDL dan genotip apo E. 
Serarnai 30 subjek Normal dan 35 Diabetes mellitus jenis 2 dikaji. Analisis biokimia lipid ditentukan secara 
automatik rnenggunakan kit komersial. Saiz LDL ditentukan rnenerusi mikroskop elektron transmis i. LDL! dan 
LDL2 adalah bersaiz besar rnanaka\a LDL3, LDL4, dan LDL5 adalah bersaiz kecil dan dianggap 
rnemudaratkan kesihatan. Genotip apo E pula ditentukan menerus i tindakbalas rantai polirnerase dan 
polimorfisme kepanjangan fragmen restriksi. 
Penemuan 
• Pesakit diabetes mellitus jenis 2 yang berlebihan berat badan mempunyai lebih banyak LDL4 berbanding 
seseorang normal 
• Kandungan LDL4 berkad:tr terus dengan aras TG plasma. Ini menunjukkan hipertrigliseridemia 
menyumbang kepada pembentuka:1 LDL4 dalam kes diabetes yang dikaji 
• Kandungan LDLI berkadar songsang dengan LDL3. Ini rnenunjukkan LDLI bertukar menjadi LDL Iebih 
kecil, pertukaran ini berterusan dan mengakibatkan banyak LDL3 terbentuk 
• Genotip £412 bercirikan LDLC paling rendah dan HDLC paling tinggi. Genotip ini adalah baik bagi 
pesak.it diabetes yang berlebihan berat badan kerana rnempunyai risiko paling rendah untuk mendapat 
penyak.i t jan tung iskemia . · 
• Genotip £4/3 b~rcirikan TG paling tinggi, LDLC paling tinggi, TC paling tinggi, dan HDLC paling 
rendah. Genotip ini tidak baik bagi pesakit diabetes yang bedebihan ber.at badan kerana mernpunyai risiko 
paling tinggi untuk mendapat penyakitjantung iskemia 
• Genotip £3/3 (normal) mempunyai risiko perantara untuk rnendapat penyakitjantung iskemia 
Kesimpulan 
Saiz LDL dan genotip apo E perlu ditentukan untuk pesakit diabetes mellitus jenis 2 yang berlebihan berat 
bad an kerana mereka berpotensi tinggi untuk mendapat penyak.it jan tung iskemia. Semasa mengurus perawatan 
esakit berkenaan, kedua-dua LDLC dan TG erlu di antau ra i sehingga 4 jam ost randial "ika boleh. 
Diabetes mellitus is a metabolic disorder characterised by chronic hyperglycaemia and dyslipidaemia, which 
places diabetics at increased risk of cardiovascular disease. We strongly believed that LDL cholesterol (LDLC), 
triglycerides (TG) and apolipoprotein E (apo E) genotype are closely related in determining this high risk. This 
study aims to study the effect of LDL subfraction and apo E genotype on diabetic dyslipidaemia. Normal 
(n=30) and diabetes mellitus type 2 (n=35) subjects who were not on any drug treatment were studied. Lipid 
biochemical analysis was performed by automated methods using commercial kits. LDL size was determined 
by transmission electron microscopy. LDLI and LDL2 are large panicles while LDL3, LDL4, and LDL5 are 
smaller particles and are considered detrimental to health. Apo E genotype was determined by polymerase 
chain reaction and restric tion fragment length polymorphism. 
Findings 
• Overweight diabetes mellitus type 2 subjects have significantly more LDL4 corr.pared to normal 
• LDL4 content varies directly with plasma TG. This indicates that hypertriglyceridaemia contributes to the 
formation of LDL4 in the diabetics who were studied 
• LOLl content varies indirectly with LDL3. This indicates that LDL I is converted to smaller LDL, this 
conversion continues and results in abundance of LDL3 
• e4/2 genotype is characterised by lowest LDLC and highest HDLC. This genotype is considered good for 
overweight diabetics as it confers the lowest risk for ischaemic heart disease 
• £4/3 genotype is characterised by highest TG, highest LDLC, highest TC, and lowest HDLC. This 
genotype is considerd not good for overweight diabetics as it confers the highest risk for ischaernic heart 
disease 
• Normal £3/3 genotype confers intermediate risk for ischaernic hean disease 
Conclusion 
LDL size and apo E genotip should be obtained for overweight diabetes mellitus type 2 patients b h 
are a t increased risk for getting ischaemic heart disease. When manaoina the treatment of thes th ecause_ t ey 
ld b I 1 . o "' . e ese patre nts both LDLC dan TG shou e c ose momtored u to 4 hours ost randially if ossible . ' 
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Charaterization of Low Density LiJloprotein Subfraction Profile and AP<>E 
Genotype among Diabetic Patients 
Shahrul, B.S. H .. Wan Mohamad--W. B.*. and Faridah. A. R. 
Dept. or Chemical Pathology and *Medicine. School of rvtedical Sciences 
Univcrsiti Sains Malaysia. 16150 Kubang Kerian. Kdantan 
The preselll study aimed to exmnine the association between diabetes mellitus type 2 with 
low density lipoprotein particle size distribution and the influence of apolipoprotein E 
genotype in altering lipid profile. A nun1ber of 35 subjects with diabetes mellitus type 2 
without having any drug treattnent were enrolled in this study. Results obtained vvere 
cotnpared with 30 normal control subjects. Blood san1ples \Vere taken after an overnight 
fast of 10-12 hours. Biochemical analysis was done using enzymatic aut01nated n1ethod 
(Hitachi 912) for the deten11ination of total cholesterol, HDL cholesteroL LDL 
cholesterol. triglyceride, and glucose concentration. LDL subfraction area under curve 
percentage (%> AUC) \Vas determined by using non-denaturing 2°/o-16 °/o polyarcylatnide 
gel electrophoresis and APOE gene analysis was by restriction fragment length 
polymorphism (RFLP) method. Lipid profile test results showed the male diabetic subject 
had higher triglyceride and LDL cholesterol value. Whereas, female diabetic subjects had 
higher total cholesterol, triglyceride, HDL cholesterol, VLDL cholesterol and glucose 
concentration. Correlation studies indicate a positive and si1:,rnificant between triglyceride 
concentration and AUC LDL 4. Triglyceride also correlated positivdy and significantly 
with glucose concentration. This indicates that hypertTiglyceridaemia could lead to the 
formation of small LDL particles. Looking into the correlation between the LDL 
subfraction, the AUC of LDL 1 correlated negatively with the AUC of LDL 3. Diabetic 
subject generally were found to have higher AUC value for the stnaller LDL particles 
which comprises LDL 3, LDL 4, and LDL 5. The study on the APOE gene showed the t:3 
and E4 subjects had high total cholesterol and glucose concentration. Diabetic individuals 
with the t::2 allele did not have any significant difference in concentration with the £3 and 
f:4 allele carriers when the triglyceride concentration was compared between the three 
allele carriers. Allele frequency seen in this groups of diabetic subjects was r.2 (0.143 }, r.3 
(0.714) and ~W4 (0.143). frequency distribution obtained was similar to the findings froin 
study on diabetic mellitus typ~ 2 subjects by Boerni et. a/ ( t 995 ). Frequency comparison 
with the non-diabetic subjects sho\v the t2 allele frequency was higher in diabetic 
subjects. 
INTRODl iCTI()N 
An increase in the number of individuals with type 2 diabetes has been reported 
worldwide~ with the n1ost drarnatic increase occurring in developing countries. h \vas 
reported by Mafauzy et. al ( 1999) that the prevalence of diabetes tne11itus increased when 
subjects are beyond 40 years of age ( 10.1 °/o ). Almost 72°/o of the diabetic subjects had 
hypercholesterolernia and 31.9°/o had tnixed hyperlipidaernia. The prevalence of type 2 
diabetes varies \Vith population age, genetic, and environmental factors. Besides it, other 
confounding factors are dietary intake, ethnic group, body mass index (BMI'), and lack of 
exerctse. 
Diabetes mellitus is a vascular disease as it is related to macro vascular and micro 
vascular diseases. Nearly 75o/o of diabetic patients die of an atherosclerotic event~ and the 
incidence of coronary artery disease is increased 2- to 4-fold in the diabetic cmnpared to 
non-diabetic subjects (Hsueh & Law, 1998). The clustering of type 2 diabetes, a weil 
documented risk factor for cardiovascular disease (CVD) with other established risk 
factors such as dys1ipidaemia, hypertension, and abdominal obesity is well recognized. 
Each risk factor conveys its significant CVD risk and in combination they place the 
person with type 2 diabetes at substantial CVD risk. This clustering has been labeled the 
metabolic syndrome, dysmetabohc syndrome or insulin resistance syndrome. Recognition 
of these features in people with type 2 diabetes has special importance in treating these 
subjects with appropriate treatment regimens. 
Lifestyle changes interact with underlying genetic factors and this accelerates the 
manifestation of metabolic syndrome. The recent National Cholesterol Education 
PrograJn Adult Treatment Panel (NCEP ATP) Ill guidelines recognize the importance of 
multiple 1netabolic syndrome disordefS, as seen in the metabolic syndron1e, and 
rcconunended an aggressive lifestyle modification approach followed by drug therapy in 
those who fail to respond to non pharmacological measures. However, the absolute 
percent of coronary artery disease (CAD) reduction is only I o/o to 2°/o. The greater 
trcatn1ent effect is hindered by a number of possible explanations, such as in1luence of 
other traditional CAD risk factors (hypertension, low HDL-cholestcrol, high-fat diet, 
obesity, lack of exercise. lack of com pi iance with drug regin1en. and not reaching 
r~coNnNnended LDL goal by NCEP ATP Ill. However, a critical factor that often remains 
after treatment is the presence of small, dense LDL particle in large quantity which is not 
detected by current LDL detennination. It is calculated based on Friedewald calculation 
(NCEP A TP Ill report, 2001 ). This indicates the importance of early identification of 
individuals at high risk of CVD who have increased atherogenic small LDL particles. 
Apolipoprotein E (apoE) is the key protein 1n transportation of lipids, and its 
poly1norphism is recognized as one of the most i1nportant genetic detern1inants for CAD 
(Mahley, 1988). On a population basis it has the strongest impact on plasma lipid levels 
presently known for a single gene polymorphism. Genetic polymorphism is an important 
cause of aberrant lipoprotein metabolism and increases the CAD risk (Kataoka et. al, 
1997; Kalix, et. al, 2001 ). The gene for apoE is polymorphic. It has three common alleles, 
which consist of epsilon 2, epsilon 3, and epsilon 4, and each code for three major 
isoforms, resulting in six comtnon phenotypes. These isoforms vary in their receptor-
binding affinity, with a poE 4 having the greatest receptor binding and apoE2 having less 
than two percent binding affinity. Individuals with apoE2 are reported to have higher 
levels of triglycerides and in hmnozygote even great increase in concentrations of 
remnants were observed, which results in type III dyslipidaemia (Zhao et. al, 1994 ). 
Individuals with epsilon 4, conversely, tend to have striking increase in LDL cholesterol 
(Kesaniemi et al, 1987). We designed this study in order to characterize the LDL 
subfraction pattern and to study the APOE gene polymorphism among type 2 diabetics 
compared to non-diabetic subjects. 
1\'t ETII()I)S 
pu~jecWts 
New diagnosed subjects attending the lipid clinic at Hospital Univerisiti Sains Malaysia 
\verc recruited after screening the folders at the record ofTicc. Type 2 diabetic patients 
w~r~ confinncd by fasting venous blood glucose levels according to the WHO year 2000. 
Alter informed consent was given, fasting blood san1plcs were tak~n f(lr n1easuren1ent of 
lipids and lipoproteins. 
Hiochernical analyse.,· 
Total cholesterol, triglycerides, and glucose were determined by colorimetric enzy1natic 
assay \vith Hitachi chemistry analyzer using BioMeriux reagents. LDL cholesterol was 
calculated based on the Friedewald fonnula and HDL cholesterol was measured after 
precipitation. Lipid and other lipoprotein were precipitated using the phosphotungstic 
acid and magnesium ion precipitation method. Anthropometric measurements included 
\veight and height. Individuals were categorized into normal weight~ ovenveight, and 
obese based on BMI < 25 kgm-2,;;::: 25 kgm-2 and~ 29 kgm-2, and >29 kgm_2 respectively 
(Boemi et. al, 1995). Persons were classified as diabetic when fasting venous plasma 
glucose \Vas ;;::: 7.0 mtnol/L. In the absence of symptoms, diagnosis was confirmed by an 
additional high glucose level result on another day. Absence of diabetes among the 
control subjects was con finned by measurement of fasting glycaemia. 
/./)/, su~fractionation 
The contents and conditions of electrophoresis were the two matn parts involved in 
optimizing of a non-denaturing linear gradient PAGE. Preparation of materials was based 
on Li et al. ( 1997). Gel contents, and electrophoresis conditions \vere optimization before 
and gel calibration step. 
The polyacrylamide gel was standardized with lipid control, lipoprotein deficient serum 
(LPDS), purified HDL, polystyrene latex beads, and purified albmnin. Electron 
micrographs were obtained using the Philips CM 12 transmission electron tnicroscope 
(TEM) at 80 kV. After the electron micrographs have been obtained, further size 
detl.!rmination of the standard particles was done usmg the Leica () Win stze 
determination soft.war~. 
The migration of the gel standards \vas measured frmn the point of application (origin) to 
the middle or each band. tv1igration distance of each calibrator and their mean particle 
size (diameter) were measured basl.!d on the micrographs captured with transmission 
electron microscope. A standard curve Vias plotted based on mean particle size (diameter) 
measured for each of the calibrators and its tnigration distance frotn origin. This plot was 
later used to determine the size of each LDL subclass. Scanning results of sample 
migration \vere later referred to the standard curve to identit)' th~ LDL subclass~s present 
in each satnple and its area under curve percentage (AUC 01o) . 
. lJ>()J-." ,'!.t'Jl(JI_\j)/11.1!, 
The amount of blood drawn was 5 tn1. The EDTA and plain were used to collect the 
blood samples and 2.5 ml was placed in each tube before centrifuging at 3,500 rpm for 5 
minutes. 
For apo E genotyping, genomic DNA \vas isolated frotn leukocytes by standard tnethod 
and atnp1ification was done using the modified method of Hixon & Vernier ( 1990). The 
5' part of exon 4 of the hUJnan apo E gene at chromosotne 19q 13.13-19q 13.32, coding for 
atnino acids 61-174 was mnplified by the polymerase chain reaction (PCR ). The hUJnan 
apoE gene exhibits three common variants (E2, E3, and E4) vvhich differ frmn each other 
at residue 112 and 158 in the mature protein. E4 has arginine (DNA sequence for the site 
GCGC) and E2 has cysteine (GTGC) at both sites, whereas E3 has cysteine (GTGC) at 
site 112 and arginie (GCGC) at site 158 (Wang et. a1, 1995 ). A section of a poE DNA that 
contains the genotype differentiating sites was amplified by PCR. The prin1crs sequences 
arc as stated following: 
1:6 upstream pritncr 
F4 downstream pritncr 
5 '-TAAGCTTGGC ACGGCTGTCCAAGG A-3. 
_ 5' -ACJ\GAJ\ TTCGCCCCGGCCTC"JGT J\CJ\C-3' 
The PCR cycles consist of sample preheating at 95°C for 5 1ninutes in 50 ~d PCR reaction 
n1ixture including dNTP and 'l'aq polymerase. The preheating \vas followed by 
denaturation at 95°C for 1 1ninute and subjected to annealing of the primers to the 
single-stranded DNA at 60°C for 1 minute. and extension of the primers in both 
directions along the template at 70°C for 2 minutes. Newly synthesized fragn1cnts in turn 
serve as templates for a chain reaction which results in the exponential amplification of 
the target sequence. The second cycle begins vvith 95°C for 1 minute unti I 30111 cycle is 
completed after 3 hours. 
Partial amplification of cxon 4 of the apoE gene generates a DNA fragn1ent of 244 base 
pairs (bp) \vas then subjected to Hhal fr01n Haemophilu ..... · haemo~vticus digestion for 
overnight at 37°(. Hhal cleaves at GCG*C. The fragtnent contains four constant and two 
polymorphic Hhul sites (fig. I). Restriction enzytne digestion of the fragment and 
electrophoresis allow the products of the six different apoE genotype as shown in table 1. 
Fragments were visualized by ethidium bromide staining after electrophoresis in 17.8°/o 
polyacrylamide gel. Electrophoresis was conducted at the voltage of 140 for 110 minutes 
with the tris-acetate-EDT A (T AE 5X) buffer. 
Table I: Genotype diagnostic fragtnent size 
Fragment size (bp) 
£212 £313 £4/4 E3/2 
91 91 91 
83 83 
72 
48 48 48 
38 38 38 38 X 2 
£4/2 
91 
83 
72 
48 
38 X 2 
£4/3 
91 
72 
48 
38 X 2 
35 35 35 35 35 X 2 
tRNag~oJstfct~ag~J;;.~JisJ·;i~o~Ty 91 ?P· 83 bp, 72 bp. and_~8 bp. af~Ter~;cebetween the 
six genotypes could be. deter~rned by t_hese specllrc _combrnatrons. Symbol x 
indicates the presence of two frag•nent w1th the same srze and it reflects double 
florescence under ultra-v_iolet visualization. 
Alcllc frequency was calculated based on the gene-counting tnethod (Garry el. al 1999). 
r.2=N212 + EM.RFk~t2 + (0.5)N.,,2 
*Niota I 
t:3'-: k~I~ l EM.RFkv~~j_p.RF~i.D 
N"•t:il 
tW4=kW!i~ + EM.RFk~i2 + (0.5 FkJtW.~ 
Niota) 
• N is the nUJnber of subjects 
,\'tal is! icalunah ·ses 
Statistical analyses were perfonned using the SPSS version I 0 for windows software. 
Students t-tests 'vere used for continuous variables and chi-square (:X 2 ) tests were used for 
categorical variables to test for statistical significance. Statistical significanc~ was 
defined as a two-tailed p-value <0.05. Results are presented as tnean ± standard deviation 
for the parameters in each group. 
RESULTS 
/,/ )/. su~fi·act ion 
Up to five distinct peaks were seen \Vithin the range of 23 tnn1-25 tntn frotn the origin 
(Fig.l ). LDL subclass sizes were: LDL 1 (27.8 nm), LDL 2 (25.1 ± 1.35 nm). LDL 3 
(22.4 ± 1.35 nm), LDL 4 ( 19.7 ± 1.35 nm), and LDL 5 ( 17 nn1). 
A/)()/:· genotyping 
Six of the genotypes of APOE are depicted in figure 2, 3, and 4. DNA fragtnents size 
varies in each genotype based on the presence of base substitution at sites 112 and ISH 
within the amplified region of the gene. The determination of each genotype was done by 
the diagnostic fragment sizes. 
~! 
I I I I P;.0 
20 25 
y~~ 
20 25 
(A) LDL 1 subfraction (B) LDL 2 subfraction 
20 25 
(C) LDL 3 subfraction (D) LD L 4 subfraction 
25 
(E) LDL 5 subfraction 
Figure 1: Densitometric scans of LDL subfractions 
These are the scanning images of the 2% - 16% gradient gel after staining with Oil Red 
0. Electrophoresis was performed for 5 hours with citrate-borate-EDT A buffer, pH 8.3 at 
20 °C. 
(e) 4/3 4/2 3/3 3/3 4/3 3/2 3/3 L 
91 bp 
72 bp 
48 bp 
38 bp and 35 bp 
L indicates I 0 bp DNA ladder 
Figure 2: Four genotypes comprising of e4/3, e4/2, e3/3, and e3/2. 
(e) L 4/3 4/4 4/2 4/4 3/2 4/3 L 
72 bp 
48 bp 
38 bp 
35 bp 
L indicates I 0 bp DNA ladder 
Figure 3: Fragment sizes of e4/4 genotype. 
(e) 2/2 3/3 3/3 3/3 
91 bp 
83 bp 
38 bp 
Figure 4: Fragment sizes of E2/2 genotype 
( iender c:_f/i!ct 011 lipid prc~fiLe 
Herein, triglycerides was higher among diabetic females compared to non-diabetic 
fen1ales. Presence of estrogen in females decreases the apoE retention time on VLDL 
particle (Kushwaha et. al. 1991 ). Hovvever, in n1ales, testosterone increases lipoprotein 
lipas~ activity. As a result. triglycerides are increased an1ong females and reduced in 
maks. c~mak subjects in either diabetic or non-diabetic group had higher total 
cholesterol and LDL cholesterol. However, there was no significant differences in 
diabetic group for both of these parameters when gender etl'ect was compared. 
Hiperinsulinemia results in increased cholesterol and there is no significant gender effect. 
Triglycerides were only raised in diabetic fetnale subjects. HDL was higher among 
fetnales and in contrary tnale subjects had lowered HDL cholesterol level. Inhibition of 
LpL activity mnong females by estrogen contributes to the increase in triglyceride but 
indirectly it causes an increase in HDL cholesterol. 
Fora/ chv/esterolund LJJL c:holesterol 
The diabetic £4 allele carriers were found to develop high LDL cholesterol compared to 
the £2 allele carriers. Similar results was reported by (Kataoka et. al, 1996 ). Ho\vever, 
total cholesterol was increased among the £3 and £4 allele carriers with diabetes. 
Generally, £4 allele was found to be correlated with increased LDL cholesterol in both 
groups. Negative feedback do\vn-regulation happens \vhen the amount of cholesterol is 
increased beyond its bound. Further intake of cholesterol is suppressed by reducing the 
number of LDL receptors at hepatocytes (Davignon, et. al, 1988). 
Ji·ig/ycerides 
In the presence of the £4 allele distinct increase of triglyceride to above normal cut off 
value vvas seen in this study. Unexpectedly, subjects with the r,3 allele were found to be 
having increased triglycerides. We had presUJncd that subjects the with £3 allele would 
show lowest triglyceride level as have been reported previously. The increase in 
triglyceride level among the e4 allele carriers having diabetes was due to the inhibition of 
lipoprotein lipase activity (Dallongeville et. al, 1992). 
II/)/, cholesterol 
Generally, t:2 allele earners either diabetic or non-diabetic had the highest HDL 
cholesterol. Ho\vever, t::3 allele carrier of both group showed the lowest level. Female 
subjects, those \vith the v,3/2 allele were among the group with the highest HDL 
cholesterol. It was found that apoE2 and apoE3 form stable complexes with HDL and 
subjects with this particular isoforms show high HDL level ( Weisgraber. 1990). In vivo 
and in vitro studies have sho\vn that apoE plays an i1nportant role in the regulation of 
cholesteryl ester transfer protein (CETP) activity. This 1nay explain the relationship 
between apoE polymorphism \vtth HDL cholesterol. ApoE has also been suggested to 
modulate lipoprotein lipase (LpL) activity, and individuals \Vith higher LpL activity are 
expected to have high HDL cholesterol. 
lfpE~llppflk 
Forn1ation of small LDL is found to be intluenced by triglyccrides concentration in this 
study. Hov;ever, reduction in AUC0/o of large LDL particles inversely correlated with 
changes of smaller LDL particles especially LDL 3 AUC%>. Similar findings have been 
reported, where LDL 4 correlated positively with VLDL and IDL (Shen et. a1, 1981 ~ 
Krauss & Burke, 1982). Coresh et. al (1993) found triglycerides to be a detenninant of 
the LDL subfraction characteristic and to be correlated with development of coronary 
artery. However, they reported age and gender wi11 not influence lipid profile. We found 
triglycerides concentration to be marginally significant in its positive correlation with 
glucose concentration. Thus, we hypothesize that hyperglycemia could contribute to the 
fonnation of small, dense LDL particle especially among diabetic subjects. Nishina et. al 
( 1992) claimed that LDL B subclass which is a atherogenic phenotype has a connection 
with the LDL receptor and insulin gene at the short arm of the 19th chromosome. 
Insulin resistance is associated with increased non-esterifies fatty acid tlux to the liver, 
increased hepatic output of large VLDL which is not suppressed postprandially, 
hipcrlipidacmia and increased cholesterol ester transfer protein activity. All of these 
factors are the possible reason for the formation of small LDL particles observed in this 
study. The :tncchanism responsible for the relationship of -hyperglycemia or 
hyperinsulinemia with high triglyceride and high LDL cholesterol concentration is due to 
the factor of reduced enzytnatic activity involved in lipid metabolistn. Differences in 
insulin action or plastna insulin level may affect the activity of both these enzytnes. The 
presence of glycosylated LOL and small LDL increases the LDL of cholesterol. This is 
explained by the reduced binding ability to the LDL receptors than the norrnal LDL. A 
decrease in the size of LDL confers additional atherosclerotic risk to this group of 
individual with diabetes tnellitus type 2. 
Frequency of each genotype mnong diabetic subjects in our study differed when we 
cotnparcd with the non-diabetic Asian population APOE genotype frequency. However, 
comparison with result obtained in the study conducted by Boen1i et. al ( 1995) on 
diabetic subjects revealed almost sitnilar frequency. Further analyses were perfonned on 
the impact of these polymorphisms on lipid and lipoprotein n1etabolism. Epsilon (£) 
which cotnprises £2, £3, and £4 effects on plastna lipid and lipoprotein we're studied 
separately and we noticed triglycerides, VLDL cholesterol, and glucose to be increased in 
all three allele carriers with diabetes. However, total cholesterol and LDL cholesterol \:vas 
raised only in £3 and £4 allele carriers \:vith diabetes. Apparently, £3 allele carriers had 
high LDL cholesterol in the presence of diabetes tnellitus type 2. Only non-diabetic E2 
allele carrier had the highest HDL cholesterol. HDL cholesterol level among £2 and £3 
allele carriers with diabetes was reduced compared to their control non-diabetic group. 
This indicates impaired synthesis of HDL particles during hyperinsulinemia. In contrast, 
£4 allele carriers did not show any reduction in HDL cholesterol compared to the E4 non-
diabetic subjects. 
Triglycerides were similar between all three allele carriers among the diabetic subjects. 
However, previous studies have reported that only subjects \:vith the £2 allele have the 
tendency to have increased triglyceride concentration. We assume that in the presence of 
insulin resistance, diabetic subjects are prone to have increased triglyceride especially 
among the sA allele carriers. Generally, presence of insulin resistance exacerbates the 
effect of APOE gene polymorphism on lipid and lipoprotein metabolism. 
In sutnmary. there \vas a higher percentage of diabetic subjects with £2 and ~W4 alleles. 
The £4 allele carriers of diabetic group could be categorized as having higher risk of 
developing atherosclerosis due to increased LDL cholesterol, total cholesterol, and 
triglyceride but reduced I-IDL cholesteroL Surprisingly, the £3 allele carriers of diabetic 
group also had increased triglyceride level. This indicates in the presence of insulin 
resistance. aberration to norn1al lipid and llpoprotein metabolism occurs even atnong 
individuals \Vith the norn1al £3 variant of APOE gene. A conclusive result on the 
influence of APOE genotype polymorphism on plasma lipid and lipoprotein levels in 
diabetics could cotne frotn the analysis of a larger satnple of subjects. 
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LAMPIRAN 1 
KAJIAN A WAL MEN GENAl GENOTIP APOLIPOPROTEIN E DAN FREKUENSI ALEL DI 
KALANGAN SUBJEK SIHAT 
PRELIMINARY STUDIES ON APOLIPOPROTEIN E GENOTYPES Al~a ALLELE FREQUENCY 
AMONG HEALTHY SUBJECTS 
Shahrul BSH, ca~idah AR 
Department of Chemical Pathology, School of Medical Sciences, 
Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
ABSTRAK/ABSTRACT 
Kajian ini menentukan geriotip apolipoprotein E dan frekuensi allel dalam kalangan individu sihat. Penentuan 
genotip apo E dianalisa dengan kaedah polimorfisma rangkaian fragmen terpilih (RFLP). Kolesterol dan 
trigliserida ditentukan dengan kaedah berautomasi: Ko!esterol lipoprotein berketumpatan rendah (LDL) 
diperoleh dari pengiraan Friedewald manakala kolesterol lipoprotein berketumpatan amat rendah (VLDL) 
ditentukan dengan membahagikan kepekatan trigliserida dengan pemalar 2.2. Kolesterol lipoprotein 
berketumpatan tinggi (HDL) dotentukan dengan kaedah pemendakan asid fosfotungstik dan ion Mg. 
Frekuensi ale! epsilon 3 didapati lebih tinggi di kalangan wanita berbanding dengan lelaki sebanyak 5.2% 
manakala terdapat peningkatan sebanyak 8.3% dan 66.7% pada subjek lelaki dengan aiel epsilon 4 serta 2. 
Kepekatan trigliserida dalam pembawa E3/3 adalah 1.79 mmol/L manakala dalam E4/2, E212, E3/2 dan E4/3 
adalah lebih tinggi iaitu sebanyak 60.3%, 53.6%, 47.5% dan 10.6% dalam turutan. HDL adalah hampir sama 
bagi setiap genotip dan kepekatan LDL didapati meningkat sebanyak 46.2% pada subjek E212 dan sebaliknya 
pada subjek E4/2 sebanyak 13.8%. Kepekatan VLDL didapati lebih tinggi pada subjek E412, E2/2, E3/2 
sebanyak 67.9%, 60.3 % dan 53.8% dalam turutannya. Genotip E4/2 dicirikan oleh kepekatan trigliserida dan 
VLDL yang tinggi. Ciri ini juga diperhati pada subjek dengan E212 yang mempunyai kandungan ko!csterol 
LDL yang tinggi berbanding dengan genotip lain. 
This study ascertained apolipoprotein (apo) E genotypes and allele frequency among healthy subjects. The 
apo E genotype was ~nalyzed by restriction fragment length polymorphism (RFLP). Cholesterol and 
triglycerides were measured by automated method. Low density lipoprotein (LDL) cholesterol was calculated 
by the Friedewald formula and very low density lipoprotein (VLDL) cholesterol determined by dividing 
triglycerides by a constant of 2.2. High density lipoprotein (HDL) cholesterol was determined by the 
phosphotungstic acid and Mg ion sedimentation method. The allele frequency of epsilon 3 was found to be 
higher in females compared to males by 5.2% whereas there was an increase of 8.3% and 66.7% in the 
percentage of epsilon 4 and epsilon 2 among males. Triglycerides concentration in E3/3 carriers was 1.79 
mmo!IL while in E4/2, E212, E312 and E4/3, the concentrations were higher by 60.3%, 53 .6%, 47.5 % and 
10.6% respectively, HDL cholesterol concentration was found to be almost similar for each of the genotypes 
and LDL cholesterol concentration was raised by 46.2% in the E2/2 carrier and reduced in the E4/2 carrier by 
13.8%. VLDL cholesterol concentration was found to be higher in the E4/2, E2/2, E3/2 by 67.9%, 60.3% and 
53.8% respectively. The E4/2 genotype carriers were characterized by the higher triglyceride and VLDL 
cholesterol concentration. This was also seen in the E2/2 carrier whose LDL cholesterol was seen to be higher 
compared to the other genotypes. 
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711t National Conference on Medical Sciences, 17-18 May 2002, Universiti Sains Malaysia Health 
Campus, Kubang Kerian, Kelantan, Malaysia. 
Characterization of Low Density Lipoprotein Sub fraction Profile and Apo E 
Genotype Among Diabetic Patients 
Shahrul Bariyah Sahul Hamid, Faridah Abdul Rashid and Wan Mohamad Wan Bebakar* 
Dept. of Chemical Pathology and *Medicine, School of Medical Sciences 
Universiti Sains l.VIalaysia, 16150 Kub8Jlg Kerian, Kelantan, l.V!alaysia. 
The present study aimed to examine the association between diabetes mellitus type 2 with low 
density lipoprotein particle size distribution and the influence of apolipoprotein E genotype in 
altering lipid profile. A total of 35 subjects (19 males, 16 females, mean age 50±11 years, mean BMI 
27±4 kg/m2) with diabetes mellitus type 2 who were overweight and without any drug treatment 
were enrolled in this study. Results obtained were compared with that ofJ30 normal control subjects 
(14 males, 16 females, mean age 27±5 years, mean B!vii 23±3 kg/m2). Plain blood samples were 
taken after an overnight fast of 10-12 hours. Serum biochemical analysis was done using automated 
enzymatic methods (Hitachi 912) for the determination of total cholesterol, HDL cholesterol, LDL 
cholesterol, triglycerides, and glucose concentration. HDL cholesterol was performed after chemical 
precipitation. LDL cholesterol was calculated if triglycerides was less than 4.5 mmol/L. Otherwise, 
direct LDL cholesterol estimation was done. LDL subfraction area under curve percentage (% AUC) 
was determined by using non-denaturing 2-16 % polyacryl~ide gel electrophoresis. APOE gene 
analysis was by polymerase chain reaction Em~oF and restriction fragment length polymorphism 
(RFLP). The lipid profil test results showed tliat male diabetics had higher triglycerides and LDL 
cholesterol whereas female diabetics had higher total cholesterol, triglycerides, HDL cholesterol, 
VLDL cholesterol and glucose. There was a positive and significant correlation between 
triglycerides and AUC of LDL 4. Triglycerides also correlated positively and significantly with 
glucose. This indicates that hypertriglyceridaemia could possibly lead to the formation of small LDL 
particles. The possibility of step-wise conversion of bigger LDL into smaller LDL was studied by 
looking into the correlation between the LDL subfractions. The AUC of LDL 1 correlated 
negatively with the AUC of LDL 3. Diabetics generally were found to have higher AUC values for 
the smaller LDL particles which comprise of LDL 3, LDL 4, and LDL 5. The study on APOE gene 
showed that e3 and e4 diabetics had elevated total cholesterol and glucose. Diabetics with the e2 
allele did not have any significant difference with the e3 and e4 subjects when the triglycerides 
concentration was compared with that of the 3 allele carrier. Allele frequency obtained for diabetics 
was e2 (0.143), e3 (0.714) and e4 (0.143). The frequency distribution obtained was similar to the 
findings from the study on diabetic mellitus type 2 subjects by Boemi et. al (1995). Frequency 
comparison with the nonrial control showed that the e2 allele frequency was higher in diabetics. 
Overweight e4/3 diabetics portrayed the worst atherogenic profile with the highest triglycerides, 
LDL cholesterol and total cholesterol, and the lowest HDL cholesterol. Insulin resistance is 
associated with increased non-esterified fatty acid flux to the liver, increased hepatic output of large 
VLDL which is not suppressed postprandially, hyperlipidaemia and increased cholesterol ester 
transfer protein activity. All these factors could act in concert and possibly give rise to the formation 
of small LDL particles observed in this study. The mechanism responsible for the relationship of 
hyperglycaemia or hyperinsulinaemia with elevated triglycerides and elevated LDL cholesterol is 
due to reduced enzymatic activity of lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) 
involved in lipid metabolism. Differences in plasma insulin level or insulin action may affect the 
activity of both these enzymes. The presence of glycosylated LDL and small LDL increases the 
contribution of LDL to total cholesterol estimation. This is explained by the reduced binding ability 
of hoth thP.se ahnormal LDT. pn.rtides to LDL receptors compared to normal LDL. We therefore 
conclude that a decrease in LDL size with high propensity for small LDL 4 therefore confers 
additional atherosclerotic risk to overweight individuals with diabetes mellitus type 2, especially 
those with e4/3 genotype. 
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